1Ponti D,Zaffaroni N,Capelli C,et al. Breast cancer stem cells: An overview[J]. Eur J ,Cancer,2006,42(9) : 1219-1224.
2AI-Hajj M, Wicha MS, Benito Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci U S A,2003,100(7):3983-3988.
3Kondo T,Setoguchi T,Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line[J]. Proc Natl Aead Sci U S A,2004,101(3):781-786.
4Grimshaw MJ, Cooper L, Papazisis K, et al. Mammosphere culture of metastatic breast cancer cells enriehes for tumorigenic breast cancer cells [J]. Breast Cancer Res, 2008, 10 (3) :R52-R57.
5Ginestier C, Hur MH,Charafe-Jauffret E,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell, 2007, 1 (5) :555-567.
6Xu JX,Morii E,Liu Y,et al. High tolerance to apnptotic stimuli induced by serum depletion and ceramide in side-population cells:high expression of CD55 as a novel character for side- population[J]. Exp Cell Res, 2007,313 (9) : 1877-1885.
7Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J]. Cancer Res, 2005,65 (1 3) :5506-5511.
8Li HZ,Yi TB,Wll ZY. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells [J]. BMC Cancer,2008,8 : 135.
10Gadalla SE,Alexandraki A, Mikael S, et al. Uncoupling of the ERa regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines[J]. Bioehem Biophys Res Commun,2011,405(4) :581-587.
3Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [ J ]. Nat Rev Cancer,2005,5 (4) :275 - 284.
4Phillips TM, McBride WH, Pajonk F. The response of CD24( -/low)/CD44 + breast cancer - initiating cells to radiation [ J ]. J Natl Cancer Inst, 2006, 98 ( 24 ) : 1777 - 1785.
5Sheridan C, Kishimoto H, Fuchs RK, et al. CD44^+/CD24^- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis [ J ]. Breast Cancer Rcs,2006,8 (5) :R59.
6Al- Hajj M. Cancer stem cells and oncology therapeutics [J]. Curr Opin Oncol,2007,19( 1 ) :61 -64.
7Kondo T, Setoguchi T,Taga T. Persistence of a small subpopulation of cancer stem - like cells in the C6 glioma cell line[J]. PNAS,2004,101(3) : 781 -786.
8Ponti D, Costa A, Zaffaroni N,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties [ J ]. Cancer Res, 2005, 65 (13) :5506 -5511.
9Yu F, Yao H, Zhu P, et al. let - 7 regulates self - renewal and tumorigenesis of breast cancer cells [ J ]. Cell, 2007,131 (6) :1109 - 1123.
10Patrawala L, Calhoun T, Schneider - Broussard R, et al. Side population is enriched in tumorigenic, stem- like cancer cells, whereas ABCG2 + and ABCG22 cancer cells are similarly tumorigenic [ J ]. Cancer Res, 2005, 65 (14) :6207 -6219.
